BR112022015796A2 - Purificação de sacarídeos - Google Patents
Purificação de sacarídeosInfo
- Publication number
- BR112022015796A2 BR112022015796A2 BR112022015796A BR112022015796A BR112022015796A2 BR 112022015796 A2 BR112022015796 A2 BR 112022015796A2 BR 112022015796 A BR112022015796 A BR 112022015796A BR 112022015796 A BR112022015796 A BR 112022015796A BR 112022015796 A2 BR112022015796 A2 BR 112022015796A2
- Authority
- BR
- Brazil
- Prior art keywords
- saccharides
- purification
- ufdf
- diafiltration
- ultrafiltration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D21/00—Separation of suspended solid particles from liquids by sedimentation
- B01D21/01—Separation of suspended solid particles from liquids by sedimentation using flocculating agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
- B01D61/146—Ultrafiltration comprising multiple ultrafiltration steps
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
PURIFICAÇÃO DE SACARÍDEOS. A presente invenção refere-se a métodos de purificação de polissacarídeos bacterianos, em particular para remover impurezas de lisados celulares de bactérias produtoras de polissacarídeos, compreendendo: a) hidrólise ácida; b) uma primeira ultrafiltração/diafiltração-(UFDF-1); b) filtração através de carvão; c) cromatografia; e d) uma segunda ultrafiltração/diafiltração-(UFDF-2).
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062980134P | 2020-02-21 | 2020-02-21 | |
US202063068338P | 2020-08-20 | 2020-08-20 | |
US202163143795P | 2021-01-30 | 2021-01-30 | |
PCT/IB2021/051330 WO2021165847A1 (en) | 2020-02-21 | 2021-02-17 | Purification of saccharides |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022015796A2 true BR112022015796A2 (pt) | 2022-10-11 |
Family
ID=74867574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022015796A BR112022015796A2 (pt) | 2020-02-21 | 2021-02-17 | Purificação de sacarídeos |
Country Status (11)
Country | Link |
---|---|
US (1) | US20230085173A1 (pt) |
EP (1) | EP4107192A1 (pt) |
JP (1) | JP2021132644A (pt) |
KR (1) | KR20220144393A (pt) |
CN (1) | CN115362177A (pt) |
AU (1) | AU2021224078B2 (pt) |
BR (1) | BR112022015796A2 (pt) |
CA (1) | CA3171864A1 (pt) |
IL (1) | IL295713A (pt) |
MX (1) | MX2022010355A (pt) |
WO (1) | WO2021165847A1 (pt) |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
US4459286A (en) | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
US4808700A (en) | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
US4709017A (en) | 1985-06-07 | 1987-11-24 | President And Fellows Of Harvard College | Modified toxic vaccines |
US4950740A (en) | 1987-03-17 | 1990-08-21 | Cetus Corporation | Recombinant diphtheria vaccines |
GB8815795D0 (en) | 1988-07-02 | 1988-08-10 | Bkl Extrusions Ltd | Glazing bead |
DE3841091A1 (de) | 1988-12-07 | 1990-06-13 | Behringwerke Ag | Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung |
EP0378881B1 (en) | 1989-01-17 | 1993-06-09 | ENIRICERCHE S.p.A. | Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines |
EP0482068A1 (en) | 1989-07-14 | 1992-04-29 | American Cyanamid Company | Cytokine and hormone carriers for conjugate vaccines |
IT1237764B (it) | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
EP0471177B1 (en) | 1990-08-13 | 1995-10-04 | American Cyanamid Company | Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines |
EP0625910B1 (en) | 1992-02-11 | 2003-07-23 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Dual carrier immunogenic construct |
IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
JP3506431B2 (ja) | 1992-05-06 | 2004-03-15 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ジフテリア毒素受容体結合領域 |
ATE156710T1 (de) | 1992-06-25 | 1997-08-15 | Smithkline Beecham Biolog | Adjuvantien enthaltende impfstoffzusammensetzung |
IL102687A (en) | 1992-07-30 | 1997-06-10 | Yeda Res & Dev | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them |
PT616034E (pt) | 1993-03-05 | 2005-02-28 | Wyeth Corp | Plasmideo para a producao de proteina crm e toxina da difteria |
ES2162139T5 (es) | 1993-03-23 | 2008-05-16 | Smithkline Beecham Biologicals S.A. | Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado. |
CA2171942C (en) | 1993-09-22 | 2010-12-14 | Andrew Lees | Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
US5917017A (en) | 1994-06-08 | 1999-06-29 | President And Fellows Of Harvard College | Diphtheria toxin vaccines bearing a mutated R domain |
US6455673B1 (en) | 1994-06-08 | 2002-09-24 | President And Fellows Of Harvard College | Multi-mutant diphtheria toxin vaccines |
CA2215933C (en) | 1995-03-22 | 2009-10-13 | Andrew Lees | Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents |
GB9513261D0 (en) | 1995-06-29 | 1995-09-06 | Smithkline Beecham Biolog | Vaccines |
GB9712347D0 (en) | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
GB9713156D0 (en) | 1997-06-20 | 1997-08-27 | Microbiological Res Authority | Vaccines |
AU1145699A (en) | 1997-09-05 | 1999-03-22 | Smithkline Beecham Biologicals (Sa) | Oil in water emulsions containing saponins |
US6303114B1 (en) | 1998-03-05 | 2001-10-16 | The Medical College Of Ohio | IL-12 enhancement of immune responses to T-independent antigens |
IL138000A0 (en) | 1998-04-09 | 2001-10-31 | Smithkline Beecham Biolog | Adjuvant compositions |
GB9817052D0 (en) | 1998-08-05 | 1998-09-30 | Smithkline Beecham Biolog | Vaccine |
WO2000010599A2 (en) | 1998-08-19 | 2000-03-02 | North American Vaccine, Inc. | IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE |
CZ301212B6 (cs) | 1998-10-16 | 2009-12-09 | Smithkline Beecham Biologicals S. A. | Vakcinacní prostredek |
EP2050464B1 (en) | 1998-12-21 | 2019-08-07 | Medimmune, Inc. | Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
EP1141306B1 (en) | 1998-12-23 | 2008-05-07 | ID Biomedical Corporation | Streptococcus antigens |
DE60043930D1 (de) | 1999-03-19 | 2010-04-15 | Glaxosmithkline Biolog Sa | Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae |
EP1165796A2 (en) | 1999-04-09 | 2002-01-02 | Techlab, Inc. | Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
CZ303515B6 (cs) | 1999-04-19 | 2012-11-07 | Smithkline Beecham Biologicals S. A. | Adjuvantní prostredek |
MXPA02003068A (es) | 1999-09-24 | 2002-09-30 | Smithkline Beecham Biolog | Adyuvante que comprende un eter o ester alquilo de polioxietileno y al menos un tensioactivo no ionico.. |
KR20020038770A (ko) | 1999-09-24 | 2002-05-23 | 장 스테판느 | 애쥬번트로서의 폴리옥시에틸렌 소르비탄 에스테르와옥톡시놀의 조합물의 용도 및 백신과 관련된 이의 용도 |
GB0007432D0 (en) | 2000-03-27 | 2000-05-17 | Microbiological Res Authority | Proteins for use as carriers in conjugate vaccines |
MXPA03000103A (es) | 2000-06-20 | 2003-06-19 | Shire Biochem Inc | Antigenos de streptococcus. |
AU2002309706A1 (en) | 2001-05-11 | 2002-11-25 | Aventis Pasteur, Inc. | Novel meningitis conjugate vaccine |
EP1456231A2 (en) | 2001-12-20 | 2004-09-15 | Shire Biochem Inc. | Streptococcus antigens |
KR101052996B1 (ko) | 2003-03-13 | 2011-07-29 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 박테리아 세포용해소에 대한 정제 공정 |
WO2004083251A2 (en) | 2003-03-17 | 2004-09-30 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
GB0421083D0 (en) | 2004-09-22 | 2004-10-27 | Glaxosmithkline Biolog Sa | Purification process |
US20060228380A1 (en) * | 2005-04-08 | 2006-10-12 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
GB0522303D0 (en) | 2005-11-01 | 2005-12-07 | Chiron Srl | Culture method |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
US8598337B2 (en) * | 2006-01-13 | 2013-12-03 | Baxter International Inc. | Method for purifying polysaccharides |
EP3406635B1 (en) * | 2007-03-23 | 2022-05-11 | Wyeth LLC | Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides |
BRPI0813307C1 (pt) | 2007-06-26 | 2021-05-25 | Glaxosmithkline Biologicals Sa | composição imunogênica, vacina, e, processo para fabricar a vacina |
GB0818453D0 (en) | 2008-10-08 | 2008-11-12 | Novartis Ag | Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom |
BRPI1011753B8 (pt) | 2009-06-22 | 2021-05-25 | Wyeth Llc | conjugados imunogênicos de polissacarídeo capsular de staphylococcus aureus de sorotipos 5 e 8, seu uso e composições que os compreendem |
JP5395264B2 (ja) | 2009-06-22 | 2014-01-22 | ワイス・エルエルシー | 黄色ブドウ球菌(staphylococcusaureus)抗原の免疫原性組成物 |
RU2579900C2 (ru) | 2009-10-30 | 2016-04-10 | Новартис Аг | Очистка капсульных сахаридов staphylococcus aureus типа 5 и типа 8 |
CN102660601B (zh) * | 2012-04-17 | 2015-10-28 | 江苏康泰生物医学技术有限公司 | 快速纯化细菌荚膜多糖的方法 |
US10632144B2 (en) * | 2012-05-22 | 2020-04-28 | Gnosis S.P.A. | Low polydispersity, low molecular weight biotechnological chondroitin sulfate with anti-inflammatory and antiarthritis activity and use thereof in the prevention of osteoarthritis |
IN2015DN00694A (pt) | 2012-08-16 | 2015-06-26 | Pfizer | |
DK2935299T3 (da) | 2012-12-20 | 2019-11-18 | Pfizer | Glycokonjugationsfremgangsmåde |
CN103495161B (zh) | 2013-10-08 | 2019-06-18 | 江苏康泰生物医学技术有限公司 | 一种多元肺炎球菌荚膜多糖-蛋白质结合物的混合物及其制备方法 |
KR102099741B1 (ko) | 2014-01-21 | 2020-04-10 | 화이자 인코포레이티드 | 스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체 |
CN110787290A (zh) | 2014-01-21 | 2020-02-14 | 辉瑞公司 | 包含缀合荚膜糖抗原的免疫原性组合物及其用途 |
WO2015121783A1 (en) | 2014-02-14 | 2015-08-20 | Pfizer Inc. | Immunogenic glycoprotein conjugates |
JP2020533437A (ja) * | 2017-09-07 | 2020-11-19 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用 |
CN110172087B (zh) * | 2019-05-31 | 2021-05-11 | 中国科学院过程工程研究所 | 一种o抗原亲和介质及其制备方法和应用 |
-
2021
- 2021-02-17 AU AU2021224078A patent/AU2021224078B2/en active Active
- 2021-02-17 MX MX2022010355A patent/MX2022010355A/es unknown
- 2021-02-17 EP EP21711029.5A patent/EP4107192A1/en active Pending
- 2021-02-17 BR BR112022015796A patent/BR112022015796A2/pt unknown
- 2021-02-17 KR KR1020227032647A patent/KR20220144393A/ko unknown
- 2021-02-17 WO PCT/IB2021/051330 patent/WO2021165847A1/en active Application Filing
- 2021-02-17 IL IL295713A patent/IL295713A/en unknown
- 2021-02-17 US US17/799,992 patent/US20230085173A1/en active Pending
- 2021-02-17 CA CA3171864A patent/CA3171864A1/en active Pending
- 2021-02-17 JP JP2021022952A patent/JP2021132644A/ja active Pending
- 2021-02-17 CN CN202180021155.1A patent/CN115362177A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
IL295713A (en) | 2022-10-01 |
EP4107192A1 (en) | 2022-12-28 |
MX2022010355A (es) | 2022-09-21 |
CA3171864A1 (en) | 2021-08-26 |
AU2021224078B2 (en) | 2024-01-18 |
KR20220144393A (ko) | 2022-10-26 |
AU2021224078A1 (en) | 2022-09-08 |
JP2021132644A (ja) | 2021-09-13 |
CN115362177A (zh) | 2022-11-18 |
WO2021165847A1 (en) | 2021-08-26 |
US20230085173A1 (en) | 2023-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR121861A2 (es) | MÉTODO PARA PREPARAR UNA COMPOSICIÓN DE IgG ENRIQUECIDA A PARTIR DE PLASMA | |
EA201691696A1 (ru) | Способы очистки матричной рнк | |
MX2020005161A (es) | Proceso para la purificacion de un acido sialico a partir de un caldo de fermentacion. | |
UA99278C2 (ru) | Способ получения существенно очищенных капсульных полисахаридов из лизата клеток streptococcus pneumoniae | |
MX2009007632A (es) | Precipitacion de polielectrolito y purificacion de proteinas. | |
RU2016128955A (ru) | Способ эффективной очистки нейтральных олигосахаридов человеческого молока (очм), получаемых при микробиологической ферментации | |
UA92823C2 (ru) | Процессы получения органической соли или органической кислоты из водного сахарного потока | |
MY188566A (en) | Method to improve virus removal in protein purification | |
NZ593511A (en) | Peritoneal dialysis methods and apparatus | |
NZ590257A (en) | Method of preparing alpha-1 proteinase inhibitor | |
EP1734033A4 (en) | PROCESS FOR PURIFYING AN AMINO ACID | |
WO2013101743A3 (en) | Microorganism nucelic acid purification from host samples | |
MX2012004851A (es) | Purificacion de sacaridos capsulares de staphylococcus aureus tipo 5 y tipo 8. | |
UA95936C2 (ru) | Способ выделения бетаина | |
BR112012019406A2 (pt) | processo para purificacao de um produto de etanol bruto | |
BR112012028507A2 (pt) | processo para recuperação de etanol com extrações laterais para regular as concentrações de c3 + alcoóis | |
GEP20227408B (en) | Method for removal of impurities from bacterial capsular polysaccharide based preparations | |
AR084006A1 (es) | Procedimiento para la separacion y recuperacion de una sal de metal alcalino purificada | |
WO2010135561A3 (en) | Method for treatment and purification of seawater to recover high purity sodium chloride for industrial usage | |
MX341243B (es) | Formulacion que comprende una enzima de degradacion de proteoglicano. | |
BR112021022759A2 (pt) | Método para purificar um oligossacarídeo de interesse a partir de um caldo de fermentação | |
WO2010101855A3 (en) | Microbial derived isoprene and methods for making the same | |
IL190092A0 (en) | Protein a production and purification without using animal derived components | |
BR112022015796A2 (pt) | Purificação de sacarídeos | |
BR112014004331A2 (pt) | método para a separação e purificação de 1,4-diaminobutano a partir de solução fermentada |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25G | Requested change of headquarter approved |
Owner name: PFIZER INC. (US) |